Global containment policy duration and long-term epidemic progression: a target trial emulation using COVID-19 data from 2020 to 2022.

Int J Infect Dis

Department of Medical Statistics, School of Public Health, Sun Yat-sen University, Guangzhou, Guangdong, PR China; Clinical Research Design Division, Clinical Research Center, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, Guangdong, China. Electronic address:

Published: March 2025

Objectives: Global countries often apply containment policies (CPs) to combat infectious disease surges. Whether countries with longer cumulative duration of CPs are associated with slower long-term epidemic progression necessitates a thorough evaluation.

Methods: We collected CP and COVID-19 data of 185 territories during 2020-2022, with a total of 23 CPs. By using the target-trial-emulation and cloning-censoring-weighting approaches, we assessed the effectiveness of CPs with different cumulative durations in delaying countries from reaching the 1% and 10% cumulative infection incidence endpoints (i.e., 10,000 and 100,000 COVID-19 cases per million population respectively) over a three-year observation period.

Results: For reaching the 1% cumulative infection incidence, recommending closing workplaces, and limiting gatherings to 10 people, each presented that longer cumulative duration of those CPs is associated with a lower proportion of countries achieving this endpoint throughout 2020-2022. For reaching the 10% cumulative infection incidence, mandatory bans on public events and domestic movements, closing public transports, screening and quarantining inbound tourists, each showed similar associations. Notably, long-lasting border bans upon high-risk regions are associated with a higher proportion of countries reaching the 10% cumulative infection incidence.

Conclusion: From the long-term perspective, we highlight CPs that warrant extending the duration to achieve slower epidemic progression. By contrast, our findings demonstrate the limited effectiveness of ban on regions in slowing the long-term epidemic progression.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijid.2025.107871DOI Listing

Publication Analysis

Top Keywords

epidemic progression
16
cumulative infection
16
long-term epidemic
12
reaching 10%
12
10% cumulative
12
infection incidence
12
covid-19 data
8
longer cumulative
8
cumulative duration
8
duration cps
8

Similar Publications

Navigating Dual-Harm: Integrating Self- and Other-Harm Into Public Health Inquiry.

Am J Public Health

April 2025

Diego A. Díaz-Faes and Charles C. Branas are with the Mailman School of Public Health and Sonali Rajan is with Teachers College, Columbia University, New York, NY.

Dual-harm, the co-occurrence of self- and other-harm, recognizes the overlap between these outcomes of aggressive behavior and their potential shared causes. Little progress has been made in preventing and responding to dual-harm in the broader population, and it remains understudied in public health research. We posit that the scientific investigation of dual-harm would greatly benefit from the application of public health principles and methods.

View Article and Find Full Text PDF

Atrial fibrillation (AF) is one of the most common cardiac diseases and a complicating comorbidity for multiple associated diseases. Many clinical decisions regarding AF are currently based on the binary recognition of AF being present or absent with the categorical appraisal of AF as continued or intermittent. Assessment of AF in clinical trials is largely limited to the time to (first) detection of an AF episode.

View Article and Find Full Text PDF

Human immunodeficiency virus (HIV) infection continues to be a major global health challenge, affecting 38.4 million according to the Joint United Nations Program on HIV/AIDS (UNAIDS) at the end of 2021 with 1.5 million new infections.

View Article and Find Full Text PDF

Polyarteritis nodosa (PAN) was first described in 1852 with the first widely recognised description in 1866 by Kussmaul and Meier. Since then our concepts of the condition have evolved, with recognition of the difference between polyarteritis nodosa and microscopic polyangiitis (MPA). Classification criteria for PAN remain unsatisfactory.

View Article and Find Full Text PDF

[Dengue fever vaccination Recommendations from the Société Francophone de Médecine Tropicale et de Santé Internationale for Metropolitan France and Overseas Territories].

Med Trop Sante Int

December 2024

Président de la SFMTSI, SFMTSI Société francophone de médecine tropicale et santé internationale (ancienne SPE), Hôpital Pitié-Salpêtrière, Pavillon Laveran, 47-83 Boulevard de l'Hôpital, 75651 Paris cedex 13, France.

Dengue fever is spreading rapidly around the world, affecting nearly half the world's population. Causes include urbanization, human mobility, climate change and the spread of mosquito vectors such as In 2023 and 2024, there was a marked increase in cases and deaths worldwide. In mainland France, the increase in imported cases has generated local transmissions.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!